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Background: As a consequence of gene/genome duplication, the RTN4/Nogo gene has two counterparts in
zebrafish: rtn4a and rtn4b. The shared presence of four specific amino acid motifs—M1 to M4—in the N-terminal region
of mammalian RTN4, and zebrafish Rtn4b suggests that Rtn4b is the closest homologue of mammalian Nogo-A.
Results: To explore their combined roles in zebrafish development, we characterized the expression patterns of rtn4a
and rtn4b in a comparative manner and performed morpholino-mediated knockdowns. Although both genes were
coexpressed in the neural tube and developing brain at early stages, they progressively acquired distinct expression
domains such as the spinal cord (rtn4b) and somites (rtn4a). Downregulation of rtn4a and rtn4b caused severe brain
abnormalities, with rtn4b knockdown severely affecting the spinal cord and leading to immobility. In addition, the
retinotectal projection was severely affected in both morphants, as the retina and optic tectum appeared smaller and
only few retinal axons reached the abnormally reduced tectal neuropil. The neuronal defects were more persistent in
rtn4b morphants. Moreover, the latter often lacked pectoral fins and lower jaws and had malformed branchial arches.
Notably, these defects led to larval death in rtn4b, but not in rtn4a morphants.
Conclusions: In contrast to mammalian Nogo-A, its zebrafish homologues, rtn4a and particularly rtn4b, are essential for
embryonic development and patterning of the nervous system.
Keywords: Brain and spinal cord development, Larval motility, Morpholino knockdown, Nogo, Reticulon, rtn4, ZebrafishBackground
Reticulon 4/Nogo-A is one of the best characterized mem-
bers of the evolutionarily conserved reticulon (RTN) gene
family (RTN1, RTN2, RTN3 and RTN4) [1]. It is also
the longest of three RTN4 gene transcripts A, B and C
(Figure 1), as well as a widely known inhibitor of axon
regeneration in oligodendrocytes and myelin of the
adult mammalian central nervous system (CNS) [2,3].
Growth inhibition is predominantly exerted by two
Nogo-A domains, the Delta 20 domain in the N-terminal
portion of the protein and the Nogo-66 loop in the
C-terminal reticulon homology domain (RHD) [3]. In
addition to its activity as an inhibitor of axon growth in the
adult CNS, recent studies in mice have uncovered its func-
tional roles in neuronal development and cortical plasticity.* Correspondence: Edward.Malaga@uni-konstanz.de;
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distribution, and reproduction in any mediumFor instance, Nogo-A has been demonstrated to be present
in migrating neuroblasts and immature neurons in the
neural tube, as well as on radially and tangentially migrating
neurons of the developing cortex, affecting their motility
[4,5]. In other studies, Nogo-A was found to contribute to
long-term potentiation (LTP) in the hippocampus, ocular
dominance column formation in the visual system, and size
control of postsynaptic densities in cerebellar neurons [6-8].
Collectively, these findings suggest that Nogo-A negatively
regulates neural plasticity in the mammalian brain [3].
These defects, however, do apparently not interfere with
fertility and viability of the Nogo-A-knockout mouse,
which shows no striking phenotype at birth [9,10].
Much less is known concerning the role of the RTNs,
especially RTN4/Nogo-A, in the neurodevelopment of
nonmammalian species. In fish, such analysis is of great
interest because axons regenerate successfully in the
teleost CNS [11-15] and because neuronal projections in
the peripheral nervous system of the embryo seem to
develop abnormally when rtn4a is downregulated [16].entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
Figure 1 Schematic representation of the human RTN4 gene and its zebrafish paralogues. All three major isoforms encoded in the RTN4
gene in humans (RTN4A, RTN4B and RTN4C) possess the reticulon homology domain (RHD), which includes the Nogo66 domain. The N-terminal
region of RTN4A contains the Nogo-A-specific domain (yellow) and the neurite growth inhibitory Delta 20 (Δ20) stretch. The diagnostic M1 to M4
motifs are indicated in red. The zebrafish has two RTN4 paralogues: rtn4a and rtn4b. Rtn4a is produced in three different isoforms (Rtn4-l (blue),
Rtn4-m (green) and Rtn4-n (orange)) with the same C-terminal RHD. Rtn4b also contains the M1 to M4 N-terminal motifs (red) and presents a
distinct RHD.
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paralogues, rtn4a and rtn4b (Figure 1) [17,18]. Both pro-
teins have a conserved RHD, the hallmark of this gene
family [1], but very different N-terminal regions [18]. A
comparative study revealed that, in contrast to its mam-
malian counterpart, the Nogo-66 region in the RHD of
zebrafish Rtn4, upon binding to either the zebrafish or the
mouse Nogo receptor (NgR), promotes neuronal growth
[15]. The N terminus of zebrafish Rtn4a bears no re-
semblance, in sequence or in length, to that of mam-
malian RTN4, but four short motifs—termed M1 to
M4 (Figure 1)—were found to be conserved between
the N terminus of Rtn4b and the inhibitory Nogo-A-
specific Delta 20 domain of mammalian RTN4 [18]. To
elucidate the function of the zebrafish Rtn4b N terminus
and its M1 to M4 motifs, ongoing studies in our laboratory
aim to investigate the expression pattern of Rtn4b in the
adult CNS and its potential ability to inhibit axon growth.
Previous work by Brösamle and Halpern [16] addressed
the role of zebrafish rtn4a using morpholino (MO)-based
knockdown strategies and showed that downregulation of
the shortest splice form, rtn4a-γ [17] (hereinafter referred
to as rtn4a-n), led to misguidance of the posterior lateral
line nerve and disorder of cranial nerves in 2- and 3-day-
old embryos. Their work further suggested that Nogo–NgR
interactions may contribute to axon guidance and to de-
velopment of the zebrafish peripheral nervous system
(PNS) by channeling axons through inhibitory terrain.
Our goal in the present study was to examine the
expression and function of rtn4b in zebrafish em-
bryos, particularly in light of the similarity between
the N-terminal region and that of mammalian Nogo-
A/RTN4A (Figure 1). In addition we comparatively
analyzed the expression of zebrafish rtn4a and its role
in embryogenesis. Interestingly, and in contrast to the
Nogo-knockout mouse, our results reveal morpho-
logical defects in the formation of the spinal cord and
brain. In rtn4b-knockdown embryos, furthermore, thepectoral fin became absent or reduced and the lower
jaw was often lost. Together, the neuronal and non-
neuronal defects in rtn4b morphants were stronger
than those in rtn4a, ultimately impairing larval motility
and causing death.
Results
Expression patterns of rtn4a and rtn4b
The initial assumption that rtn4a was the closest zebra-
fish homologue of mammalian Nogo-A prompted the
characterization of its developmental expression patterns
[16]. However, the recent identification of a Delta 20–like
region in Rtn4b [18] revealed that this protein is equally
or more functionally related to mammalian Nogo-A than
to Rtn4a (Figure 1). To gain comparative insight into the
embryonic expression domains of both duplicate genes,
we performed mRNA in situ hybridization with rtn4a-
and rtn4b-specific probes. Although expression of both
rtn4a and rtn4b can be first appreciated in the gastrula
6 hours postfertilization (hpf) [16,19], rtn4a transcripts
become more abundant and were restricted to the anter-
ior half of the embryo by 18 hpf (Figure 2A). At this stage,
rtn4b expression, in contrast, was also seen in the poster-
ior part of the embryo (Figure 2D). At 1 day postfertiliza-
tion (dpf), both rtn4a and rtn4b mRNAs were highly
expressed in cells of the eye anlage and in the midbrain in
cells of the presumptive optic tectum (Figure 2C and 2F).
In addition, the rtn4a signal was detected in somite bound-
aries at 1 dpf and in skeletal muscle at 2 dpf, as previously
reported [16] (Figure 2B and 2G). Rtn4b mRNA expression
at 1 dpf was absent from somites, and, in contrast to rtn4a,
its expression was observed in the entire CNS, including
forebrain, midbrain and hindbrain, as well as in the spinal
cord (Figure 2E and 2F). The strongest rtn4a signal at 2 dpf
was observed in somites, in the brain region and in retinal
ganglion cells (RGCs) (Figure 2G and 2H). Similarly, an
rtn4b signal at 2 dpf was detected in distinct brain areas,
including the olfactory system, telencephalon, optic tectum
Figure 2 Expression of rtn4a and rtn4b genes during zebrafish embryogenesis. The developmental expression pattern of rtn4a and rtn4b
was examined by whole-mount in situ hybridization using gene-specific probes. (A) At 18 hours postfertilization (hpf), rtn4a is expressed in the
anterior part of the embryo. Between 1 day postfertilization (dpf) (B) and (C) and 2 dpf (G) and (H), we detected increased transcription of rtn4a
in the somites (s) and the eye anlage (e), as well as in the presumptive optic tectum (t). (D) At 18 hpf, rtn4b transcripts appeared along the trunk
of the embryo. (E) and (F) At 1 dpf, rtn4b expression is evident in the posterior spinal cord (sc), the developing forebrain (fb), eye anlagen (e) and
midbrain and hindbrain (hb), including the otic vesicle (ov). (G) and (H) At 2 dpf, rtn4a mRNAs are produced in retinal ganglion cells (RGCs)
(arrow), the olfactory organ (o) and forebrain (fb), as well as in somites (s). (I) and (J) At 2 dpf, rtn4b is transcribed in the forebrain (fb), including
the olfactory organ (o) and RGCs (arrow), and in the midbrain and hindbrain. At this stage, the spinal cord was no longer labeled, but the
notochord (n) began to express rtn4b. Lateral views are shown, except in (C) and (F) (dorsal views of 1-dpf embryos) and (H) and (J) (ventral views
of 2-dpf embryos).
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spinal cord, however, was no longer labeled at 2 dpf, but the
signal became visible in the notochord (Figure 2I), in
branchial arches and pectoral fins (not shown). Thus,
both genes are strongly expressed in the developing
nervous system.
Morphological defects of rtn4a and rtn4b knockdown
A previous study reported embryonic roles of rtn4a in
the PNS up to 4 dpf [16]. Our own expression data are
in agreement with these observations (Additional file 1:
parts E and F) and additionally suggest the roles of both
rtn4a and rtn4b in the CNS at later stages. Therefore, we
examined and compared their developmental functions
using the MO-knockdown approach. After running titration
and toxicity controls (Additional file 1: part B), MOs target-
ing the shared 5′ untranslated region (5′UTR) of all three
rtn4a isoforms, l, m and n (previously known as α, β and γ)
[16,17], and against each splice form separately, a sec-
ond MO against ATG as well as two MOs against rtn4b
(5′UTR, MO1; ATG, MO2) were separately microinjected,and the embryos were scored for morphological pheno-
types (Additional files 1 and 2).
In addition to using two MOs against each rtn4, we
confirmed the specificity of the MOs against rtn4a and
rtn4b by two antibodies: IK964 against the RHD of Rtn4a
and K1121 against M1-4 of Rtn4b. In immunoblots of
proteins from untreated and MO-injected embryos, the
protein-specific bands at 43 kDa (Rtn4al) (Figure 3A) and
90 and 180 kDa (Rtn4b) (Figure 3A and 3C) disappeared or
were massively reduced in MO-treated embryos. The blots
suggest that Rtn4al is the predominant form because a mix-
ture of all rtn4a MOs (MO1) caused the disappearance of
only one specific band at 43 kDa. Similarly, when Rtn4a-l-
green fluorescent protein (GFP) was overexpressed and
detected by anti-GFP, a mixture of MO1 against rtn4a-l,
rtn4a-m and rtn4a-n led to the loss of GFP fluorescence.
That the GFP antibody was able to detect the Rtn4al-GFP
fusion protein was confirmed by Western blot analysis
(Figure 3B).
We then used the antibodies for detection of Rtn4a and
Rtn4b in embryos. In immunostaining experiments, both
Figure 3 Rtn4a and Rtn4b protein levels and morpholino knockdown. (A) Western blot (WB) analysis using the zebrafish α-Rtn4a antibody
[15] shows that Rtn4a-l (an approximately 43-kDa band, arrow) is suppressed either by injection of a mixture of morpholinos (MOs) against each
rtn4a isoform or a MO against the rtn4a-l isoform. Embryos expressing an Rtn4a-l-GFP fusion can overcome the Rtn4a MO1 downregulation. GFP
antibodies detect the fusion protein at approximately 70 kDa and GFP alone at approximately 26 kDa. α-tubulin (Tub) served as a protein loading
control. (B) Exogenous Rtn4al-GFP was detected at 6 hpf, but simultaneous coinjection of rtn4a-l MO1 abrogated its expression. (C) α-Rtn4b
antibodies show the downregulation of Rtn4b for both MOs used in the experiments. The 180-kDa band (arrowhead), probably a dimerization
band, is entirely reduced in MO-injected embryos, and the 90-kDa band (arrow) shows a strong reduction. (D) through (J) Rtn4a and Rtn4b
immunostainings at various developmental stages. At 1dpf, Rtn4a is expressed in distinct neuronal structures, including the forebrain (fb), the
presumptive optic tectum (t) and the hindbrain (hb). Rtn4a is also present in the eye anlage (e), otic vesicle (ov) (D), and in muscle tissue (m) (E).
At 2 dpf, Rtn4a is detected in retinal ganglion cells (RGCs) (arrow), the optic nerve (arrowhead) and the olfactory system (o) (F). At 1 dpf, Rtn4b is
expressed in the same structures as Rtn4a except the muscle tissue (G). Rtn4b is also detected in the spinal cord (sc) (H). At 2 dpf, the Rtn4b
signal is still present in the spinal cord (sc) and can also be seen in growing primary motor neurons (arrow) (I). In the head, Rtn4b is present in
RGCs (arrow) and the optic nerve (arrowhead) (J).
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midbrain and hindbrain in 1-dpf embryos (Figure 3D
and 3G) and labeled RGCs and their axons, commis-
sures and the olfactory system in the 2-dpf embryo
(Figure 3F and 3J), consistent with the distribution of
the mRNAs. Also, K1121 against Rtn4b stained cells in
the spinal cord at 1 dpf and motor neurons and their
axons at 2 dpf (Figure 3H and 3I). IK964 against Rtn4a
bound to somites (Figure 3E) and not to the spinal cord
or motor neurons. That the antibody staining is specific
was shown in embryos injected with MOs against rtn4aand rtn4b, in which labeling was significantly reduced
(Additional file 3). This expression pattern led us to
expect morphological defects in MO-injected embryos.
Indeed, between 15 and 24 hpf, rtn4a morphant em-
bryos microinjected with a mixture of 2 ng of the three
rtn4a isoforms showed abnormalities most visible in the
head region, such as reduced eyes and mild deformations
of the forebrain (Figure 4D and 4E). The same defects
were also observed in 75% (rtn4a-l), 51% (rtn4a-m) and
30% (rtn4a-n) of the embryos, when 5 ng of MO against
each isoform were injected separately (Additional file 1).
Figure 4 (See legend on next page.)
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Figure 4 Morphogenetic defects after morpholino-mediated downregulation of rtn4a and rtn4b. (A) At 15 hpf, control embryos showed a
differentiated eye anlage (e) and forebrain (arrow). In contrast, the general morphology of rtn4a- and rtn4b-morpholino (MO)-injected embryos
was visibly affected (D) to (G). The forebrain was flattened (arrow), and the eye anlage (e) and the head were reduced in size. At 1 dpf, the heads
and eyes of embryos injected with rtn4a and rtn4b MO1 remained reduced. In particular, rtn4b morphants exhibited an abnormally curved
notochord (E) to (H). At 2 dpf, the rtn4a morphants still had reduced eyes and forebrains compared to controls (Co) (F and F′ vs. C and C′), but
no other morphogenetic defects were apparent. Rtn4b morphants had even smaller eyes, markedly shortened forebrain/midbrain regions and a
deformed fourth ventricle (I and I′, arrow). At 3 dpf, the eyes and brains of rtn4a and rtn4b morphants remained smaller (J, L and N). Rtn4b
morphants developed a thinner, ventrally curved tail; lacked lower jaws (asterisk); and had an inflated heart cavity. At 5 dpf, rtn4a, but not rtn4b,
morphants seemed to regain a nearly normal overall morphology (K, M and O). The reduction in eye size was quantified at 15 hpf in embryos
injected with rtn4b MO1 and MO2 (targeting the 5′ untranslated region and ATG, respectively) and coinjected with rtn4b mRNA (P). In rescue
experiments, the rtn4b morphant phenotype showed clear improvement (Q). Anterior brain structures selected for measurements are outlined in
yellow. Samples studied were rtn4b MO1 (n= 36), rtn4b MO2 (n = 64), rtn4b MO1 + rtn4b mRNA (n= 69) and rtn4b MO1 (n= 85). Scale bars = 100 μm.
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prominent form, a finding that is consistent with immuno-
blot results in which IK964 against Rtn4a gave one specific
band at 43 kDa, which disappeared after MO knockdown
of rtn4a-l. When rtn4a MO-injected embryos at 2 dpf
were stained with the antibody against acetylated tubulin,
the pathfinding mistake of the lateral line nerve—first
described by Brösamle and Halpern [16] for rtn4-γ
(that is, rtn4a-n)—was one striking defect in the
organization of the fiber tracts (Additional file 1: parts
E and F). Yet, it was not the sole neurological defect,
as described further below in the retina and brain
development section.
Rtn4b morphants at 15 hpf exhibited similar but
stronger defects when injected with 5 ng of MO1. The
size of the eyes was reduced and the brains were
smaller (Figure 4G, 4P and 4Q). In particular, the forebrain
appeared flattened and failed to develop distinct di-
encephalic and telencephalic regions. At 1 dpf, the rtn4b
morphants appeared abnormally curved (Figure 4H).
At 2 dpf, the rtn4a and rtn4b morphants showed in-
creasingly reduced brain sizes (Figures 4F, 4F′, 4I, and 4I′)
compared to controls (Figure 4C and 4C′). Moreover, the
fourth brain ventricle was expanded in most rtn4b mor-
phants at 2 dpf, so that the skin above the hindbrain
seemed to have lifted (Figure 4I and 4I′). The cerebellum
and posterior hindbrain regions were present. At 3 dpf,
the rtn4b morphants remained abnormally curved and
had lost motility. In addition, they had smaller heads and
lacked the lower jaw (Figure 4N). They were impaired in
their escape response and reacted to touch with one or
two swimming strokes and eventually ceased to move
altogether (Additional file 4C). The abnormal forebrain in
rtn4b morphants caused a shift of the optic tectum into
abnormally anterior positions, a phenomenon that became
even more pronounced at 5 dpf (Figure 4O and see below,
Retina and brain development section). Furthermore, the
rtn4b morphants showed an increasingly curved tail, an
inflated heart cavity and abnormal mouth and jaws, and
they died at about 7 dpf. The rtn4a morphants, in con-
trast, were less disturbed in their overall morphology(Figure 4L and 4M). Interestingly, although the motility
of rtn4b morphants appeared to be reduced relative to
control embryos, they always escaped upon touch, and
this defect did not result in lethality.
Given the severity of the rtn4b morphological knock-
down phenotypes, we ran additional tests to rule out
unspecific MO effects. To this aim, we performed rescue
experiments in which embryos were co-injected with
rtn4b MO-1 and rtn4b mRNA engineered to lack the
MO-binding site. Rtn4b morphant embryos were evalu-
ated at 14 to 15 hpf and the degree of rescue was
assessed as the proportion of embryos exhibiting mild or
strong eye and forebrain phenotypes (Figure 4P). In
contrast to the 33% strong and 67% mild phenotypes
observed among rtn4b morphants, only 2% of the rescue
embryos had strong phenotypes, 59% had mild pheno-
types and 39% looked normal (Figure 4P an 4Q). To rule
out that mRNA might induce defects on their own, we
examined rtn4b mRNA-injected embryos and found that
only 7% of them showed mild phenotypes (Figure 4P).
The results of these rescue experiments suggest that rtn4b
MO-1 plays a specific role in brain morphogenesis. This
result was supported by experiments with MO2, which
caused defects similar to those caused by MO1 in 100%
embryos (Figure 4P and Additional file 1: part D).
Roles of Rtn4b in neural development
To obtain insights into neuronal and non-neuronal de-
fects underlying the severe rtn4b morphant phenotype,
we analyzed MO-injected tg(shh:gfp)-, tg(hb9:gfp)- and
tg(Isl1:gfp)-transgenic embryos. These embryos express
GFP in the floor plate, motor neurons, cranial nerves
and retinal axons, respectively, and thus allowed us to
recognize defects in the relevant structures following
MO injections. Rtn4b morphants of tg(shh:gfp) fish at 1
dpf showed abnormalities in the forebrain, including
the ventral hypothalamic region and the dorsal inter-
thalamic structures (Figure 5A and 5B) [20]. A closer
look at the GFP signal in the notochord and floor plate
revealed undulations in the rostrocaudal axis instead of
a straight row of cells, which we observed in controls
Figure 5 Development of neural and non-neuronal structures in rtn4b-knockdown, GFP transgenic embryos. At 1 dpf, tg(Shh:GFP), rtn4b
morphant embryos showed deformations in the hypothalamic region (h), dorsal thalamic structures (arrow), anterior floor plate (f) and forebrain
(A) and (B). Additionally, the notochord (n) is abnormally undulated (compare (C) and (D)). In addition, 1-dpf tg(hb9:GFP), rtn4b morphant
embryos had fewer cell bodies in the spinal cord and truncated motor axons (E) and (F) (arrowheads). At 2 dpf, motor axons showed aberrant
branching (G) and (H) (arrows). At 5 dpf, lateral (J) and dorsal (L) views reveal smaller eyes (e), aberrant retinal ganglion cells (RGCs) (white arrow)
and few retinal axons projecting into the tectum (t), which is displaced anteriorly, along with abnormally patterned branchial arches (br) and
reduced pectoral fins (pf) (I) to (L). At 2 dpf, tg(Isl1:gfp), rtn4b-MO1 morphants showed severe defects in cranial motor neurons, including lack of
pairs III and IV (M) and (N). (O) Quantification of the number of motor neurons in posterior segments (n = 15 to 20) of the spinal cord in control
morpholino (Co MO; n = 20), rtn4b-MO1 (n = 25) and rescued (n = 20) embryos at 1 dpf. (P) Proportion of embryos with abnormal motor axons in
embryos injected with Co MO, rtn4b-MO, rtn4b-MO2, or coinjected with half concentrations of both MOs, or rtn4b-MO1 + rtn4b-mRNA, and
injected with rtn4b-mRNA. hb: hindbrain; e: eye; ob: olfactory bulb; c: cerebellum; X: branchiomeric nerve X. Co MO (n = 15), rtn4b-MO1 (2.5 ng)
(n = 30), rtn4b-MO2 (2.5 ng) (n = 31), rtn4b-MO1 (5.0 ng) (n = 17), rtn4b-MO2 (5.0 ng) (n = 11), rtn4b-MO1 + rtn4b-MO2 (2.5 ng) (n = 20), rtn4b-MO1
(5.0 ng) + rtn4b-mRNA (100 pg) (n = 69) and rtn4b mRNA (100 pg) (n = 85). Scale bar = 100 μm.
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easily apparent, were also observed in nontransgenic
rtn4b morphants (Figure 4H). Rtn4b morphants of tg
(hb9:gfp) zebrafish showed fewer motor neurons at 1
dpf and abnormal motor axon projections at 2 dpf
(Figure 5E to 5H) in correlation with the embryo’sinability to move (Additional file 4). The reduction in
the number of cells in the spinal cord and the extent of
aberrant projections observed in tg(hb9:gfp) embryos
injected with rtn4b-MO1 were partially rescued after
combined injections of rtn4b-MO1 and rtn4b-mRNA.
In posterior regions of the spinal cord (segments 15 to
Figure 6 (See legend on next page.)
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Figure 6 Retinal ganglion cell development in rtn4a- and rtn4b-knockdown, GFP–transgenic embryos. (A) through (I) tg(brn3c:mGFP)
embryos at 3 dpf exhibit labeled retinal ganglion cells (RGCs) in the eye (arrow) and RGC axons in the optic nerve and tract as well as in the
optic tectum (t). (A), (D) and (G) Lateral views of the left eye and optic tectum (anterior to the left). (B), (C), (E), (F), (H) and (I) Ventral views
(anterior to the top). (A) to (C) In control morpholino (Co MO)–injected embryos, RGC axons reached the optic tectum (t) and innervated the
neuropil (A). The ventral view shows the RGCs in both eyes (arrow) and the RGC axons in the optic nerve, the chiasm and the optic tract (B). (C),
(F) and (I) RGCs and their axons were costained with antibodies against neurolin. RGCs from both morphants, rtn4a (D) to (F) and, to a greater
extent, rtn4b (G) to (I), cover smaller areas of the retina (outlined) and their axons show aberrant pathways. (J) to (L) Quantification of eye size,
the area covered by RGCs and their ratio. (M) to (O) and (P) to (R) Rescue of the rtn4a and rtn4b RGC phenotypes. Arrow points to RGCs. (S)
Quantification at 3 dpf showing the reduction in the area covered by RGCs after injection of rtn4a- and rtn4b-MO1 (separately and combined)
and rtn4b-MO1 and rtn4b-mRNA, as indicated under each bar. Control-MO (n = 28), rtn4a-l-MO1 (5.0 ng) (n = 16), rtn4a-l-MO1 (2.5 ng) + rtn4a-l-
mRNA (100 pg) (n = 32), rtn4b-MO1 (2.5 ng) (n = 22), rtn4b-MO2 (2.5 ng) (n = 24), rtn4b-MO1 (5.0 ng) (n = 19), rtn4b-MO2 (5.0 ng) (n = 24), rtn4b-
MO1 and rtn4b-MO2 (2.5 ng) (n = 27), rtn4b-MO (5.0 ng) and rtn4b-mRNA (100 pg) (n = 23) and rtn4a-l-MO1 (2.5 ng) and rtn4b-MO1 (2.5 ng)
(n = 27). Scale bar = 100 μm.
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http://www.neuraldevelopment.com/content/9/1/818) analyzed at 1 dpf, the number of cells was reduced
after injection of rtn4b MO (approximately 6.87 cells
per segment) compared to control MO–injected em-
bryos (approximately 15.37 cells per segment). This re-
duction was partially rescued upon combined injections
of rtn4b-MO and rtn4b-mRNA (approximately 10.62
cells per segment) (Figure 5O and Additional file 4). More-
over, the proportion of embryos with strong abnormal
motor axon projections in rtn4bmorphants (approximately
75%) was reduced after coinjection of rtn4b-MO and
rtn4b-mRNA (approximately 33%) (Figure 5P). In another
group of tg(hb9:gfp) fish, we examined whether the embryos
at 3 dpf showed an escape response when touched. In the
rtn4b rescue group, 38% were able to escape, whereas only
5% of embryos escaped in the rtn4b-MO group. All em-
bryos were motile in the mRNA-injected group (Additional
file 4: part C). The partial rescue by combined rtn4b-MO
and rtn4b-mRNA injections shows that the defects were
specific for rtn4b MOs (Figure 5O and 5P).
The reduction in number of cells in the spinal cord
and the reduced brain size might be a result of increased
apoptosis, reduced cell proliferation or both. Indeed,
when 1-dpf rtn4a- and rtn4b-MO-treated embryos
(MO1 for rtn4a and rtn4b) were exposed to acridine
orange (apoptotic cells), significant increases in labeled
cells was recorded in the midbrain and hindbrain
(Additional file 5).
In embryos exposed to bromodeoxyuridine (BrdU) at 1
dpf and analyzed 1 hour later, BrdU and 4′,6-diamidino-2-
phenylindole (DAPI) labeling showed a reduction in the
total number of cells in rtn4a-MO-injected embryos, and
an even greater reduction in rtn4b-MO-injected embryos
(Additional file 6). Interestingly, the ratio of BrdU-positive
cells was identical in controls and following rtn4a-MO or
rtn4b-MO injections, indicating that the number of cells
entering the S-phase was not affected (Additional file 6:
parts H and P).
In a pulse-chase experiment in which embryos were
given BrdU at 1 dpf and analyzed 2 days later, it wasapparent that the BrdU labeling was retained in most
cells of the midbrain and hindbrain of 3-dpf rtn4b-MO-
treated embryos (see Additional file 6 for BrdU labeling
in the tectum and a related quantification in the hind-
brain), suggesting that cell proliferation was impaired
in these structures. This observation is consistent with
the massive reduction of brain size in these embryos
(Figure 4P). On the other hand, rtn4a-MO-treated
embryos showed a reduction in BrdU labeling similar to
that in control MO-injected embryos (Additional file 6:
parts E and N). Interestingly, although their brains were
smaller than those of control embryos at 1, 3 and 5 dpf
(Figure 4), this effect was not as severe as it was in rtn4b
morphants. Therefore, the rate of cell division in rtn4a
morphants was likely affected only transiently or
partially.
At 5 dpf in rtn4b morphants of the tg(shh:gfp) line
(Figure 5I to 5L), the absence of the lower jaw and of
the five branchial arches, which will form the gills, be-
came evident. Moreover, the rtn4b morphants had prob-
lems with visual system development. RGCs and their
axonal projection to the optic tectum were underdevel-
oped, and the optic tectum shifted anteriorly (Figure 5I
to 5L and next section). Moreover, the pectoral fins were
abnormal or missing. In addition, the rtn4b morphants
of tg(Isl1:gfp) embryos showed that the neurons of cra-
nial nerves III and IV failed to differentiate (Figure 5M
and 5N). Thus, rtn4b morphants had severe brain-
patterning defects and skeletal malformations.
Retina and brain development
Besides the clear differences between the rtn4a and
rtn4b expression patterns and knockdown phenotypes,
some similarities were also evident. For instance, both
transcripts appeared to be upregulated in the optic
tectum and retina, and both morphants exhibited related
morphological defects, such as smaller brains and eyes.
To better characterize neural roles of rtn4 paralogues,
we analyzed their function in the GFP-labeled
Figure 7 Brain differentiation and retinotectal projections in rtn4a- and rtn4b-knockdown, GFP–transgenic embryos. In rtn4a-morpholino
(MO)- and rtn4b-MO-injected embryos, brains are smaller both anteroposteriorly as well as laterally. (A) Extent of the tectum (t) and the forebrain
(fb) marked by white brackets in the HuC/HuD labeled brains of control embryos. (D) and (G) Knockdown of rtn4a, but more severely of rtn4b,
leads to a reduction in the size of the tectum and the forebrain. In rtn4b morphants, the olfactory placodes (arrowhead) are not clearly
identifiable and the tectum is localized in abnormally anterior positions. (B) In control embryos, the GFP–labeled retinal ganglion cell (RGC) axons
cover the tectal neuropil (outlined). (E) and (H) The RGC axons in the tectum cover a smaller area in both morphants, but more severely so in
the rtn4b morphants than in their rtn4a counterparts. GFP is also expressed in neuromasts (arrows), which are aberrantly positioned in the
morphants. (C), (F) and (I) 4′,6-diamidino-2-phenylindole (DAPI) staining of the brain shows the area of the neuropil (outlined), which is reduced
after downregulation of rtn4a and rtn4b. (J), (K) and (L) Quantification of the length of the optic tectum, forebrain and tectal neuropil in control
and rtn4a-MO- and rtn4b-MO-injected embryos. (A) to (I) Dorsal views of the brain of tg(brn3c:mGFP) embryos at 5 dpf. Control MO (5.0 ng)
(n = 10), rtn4a-l-MO1 (5.0 ng) (n = 10) and rtn4b-MO1 (5.0 ng) (n = 10). Scale bar = 100 μm.
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of rtn4a-l MO1, but more severely rtn4b MO1, resulted
in a reduction in the size of the eyes of 27% and 50%, re-
spectively, and a reduction in the area covered by RGCs
of 39% and 80%, respectively (Figure 6J to 6L). Rtn4bMO1 and rtn4b MO2 at half concentrations enhanced
each other and led to 85% severely and 15% mildly re-
duced RGC areas (Figure 6S). Rtn4b MO2 caused a
strong reduction in the area occupied by RGCs in 91%
of the embryos (and 9% mild). Moreover, rtn4a-l MO1
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synergistically, causing this effect in 100% of the
embryos.
In 3-dpf rtn4amorphants, the area of the retina occupied
by RGCs was reduced and extended markedly fewer axons
into the optic nerve and tectum (rtn4a-MO1; Figure 6D
and 6E) than in control embryos (Figure 6A and 6B). The
rtn4b morphant was more severely affected, as the area
occupied by GFP-labeled RGCs was massively reduced
and the few axons formed rudimentary optic nerves
(rtn4b-MO1; Figure 6G and 6H). To rule out the possi-
bility that axons were present in both morphants but
failed to express GFP, we performed immunostaining
with antibodies against the cell adhesion molecule neuro-
lin. These immunostained images show that the RGCs
and axons were indeed reduced (rather than being in-
visible as a result of the absence of GFP expression)
(Figure 6C, 6F and 6I). The specific roles of rtn4a and
rtn4b in retinotectal development were also confirmed
by rescue experiments in which mRNAs of the rtn4a
(isoform l) and rtn4b, respectively, were coinjected along
with the corresponding MOs. Upon coinjection of 100 pg
of rtn4a-l-mRNA, morphants with mild phenotypes
were reduced from 75% to 25% (Figure 6M to 6O and
6S). The concentration-dependency of the mRNA rescue
experiment strongly suggests that the phenotypes ob-
served were specifically caused by rtn4a downregulation.
Likewise, the rtn4b (MO1) strong phenotype was partially
rescued by mRNA coinjection. Morphants with strong
phenotypes were reduced from 87% to 52% (Figure 6P to
6R and 6S). The remaining 48%, however, remained
mildly affected. Besides supporting the specificity of
the MO effects on RGC differentiation and RGC axon
growth, these experiments also confirm the strong effect
of rtn4b downregulation on retinotectal development.
At 5 dpf, most rtn4a morphants of the tg(brn3c:mgfp)
embryos still had smaller retinotectal projections (Figure 7D
and 7E) but the reduction in size was more severe in
rtn4b morphants (Figure 7G and 7H). The tectum re-
sides in positions far too anteriorly, as mentioned above
(Figure 7G). Brains exposed to the neuronal marker
HuC/HuD and the nuclei marker DAPI, which stain all
cells and spare the tectal neuropil, highlight how small
the neuropil had become in the morphants compared to
controls (Figure 7A, 7C, 7D, 7F, 7G and 7I). A compari-
son with the controls illustrates that the tectum, the
forebrain and the neuropil in the rtn4b morphants were
reduced to 62%, 54% and 48%, respectively, of their ori-
ginal size (Figure 7G and 7J to 7L) and to 78%, 77% and
76%, respectively, in the rtn4a morphants (Figure 7D
and 7J to 7L). Again, this analysis underscores the
abnormal brain patterning in rtn4b morphants, which is
more severe than in the rtn4a morphants. In addition to
RGCs, tg(brnc3:mgfp) also expresses GFP in neuromasts.The number of neuromasts and their position was also
abnormal in themorphants (Figure 7B, 7E and 7H).
In sum, downregulation of both rtn4a and rtn4b pro-
duced clear abnormalities in the development of the CNS
and the PNS, whereby the strongest effects were observed
in rtn4bmorphants. In these embryos, specific neural struc-
tures such as the retina, the optic tectum and the forebrain,
as well as neuromasts, cranial ganglia and spinal cord, were
markedly reduced. Loss of rtn4b also led to reduced and
disorganized axon projections from RGCs, cranial ganglia
and motor neurons, and ultimately to larval death. Outside
the nervous system, rtn4bmorphants suffered from the loss
of lower jaws, shorter or absent pectoral fins and notochord
abnormalities in correlation with the increasingly curved
tail. In rtn4amorphants, the retinotectal defects were quali-
tatively similar to those in rtn4b morphants, but overall
were less severe and apparently reversible with time. The
cranial nerve and lateral line misprojections of rtn4a mor-
phants reported by Brösamle and Halpern [16], together
with early forebrain defects, seemed not to be lethal, at least
not in the first weeks of life.
Discussion
Although knockout of RTN4/Nogo-A in mice produces
viable animals without obvious morphological defects in
the brain [9,10], our study results show clear neurodeve-
lopmental defects upon downregulation of both zebra-
fish RTN4 homologues. In particular, zebrafish rtn4b
plays essential roles in the early development of the ner-
vous system and in the morphogenesis of the notochord
and jaws. In the nervous system, the most striking
effects of rtn4b downregulation were reduced number of
motor neurons and abnormal motor axon pathfinding,
reduced eye and brain size, abnormal retinotectal projec-
tion, fewer and mislocalized neuromasts and axon
pathfinding errors of cranial nerves and nerves of the
anterior and posterior lateral lines. The severity and
lethality of these defects indicate that, unlike zebrafish
rtn4a and mammalian RTN4, rtn4b is vital for zebrafish
embryonic development. Our MO data further show
that zebrafish rtn4a also contributes to CNS and PNS
development, although to a lesser degree than rtn4b.
This synergy between the neurodevelopmental roles of
rtn4a and rtn4b is consistent with their expression in
partially overlapping domains of the brain. Differential
expression was restricted mainly to posterior regions of
the embryo, where rtn4a was detected in lateral line
ganglia and somites, and rtn4b was detected in the
spinal cord. Unlike rtn4b-knockdown embryos, rtn4a
morphants, although less motile relative to controls,
always escaped upon touch, survived for weeks and
seemingly recovered some of the earlier abnormalities.
Among the most striking abnormalities shared between
the rtn4a and rtn4b morphants were their strongly reduced
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to have shifted into abnormally anterior positions, possibly
as a consequence of the reduced forebrain size, and
received a small number of RGC axons from the few
remaining RGCs. This observation suggests that rtn4a and
rtn4b are involved in neuronal differentiation and/or the
maintenance of normal cell numbers in specific areas of the
nervous system and therefore may be required for cell pro-
liferation, cell survival and pattern formation in specific
subdivisions of the CNS and PNS. Our previous bioinfor-
matic analyses strongly suggest that the Rtn4b N-terminal
domain is directly homologous to the corresponding Delta
20-containing region of mammalian Nogo-A [18]. How-
ever, downregulation of RTN4/Nogo-A in mammals does
not obviously impair cell proliferation, neuronal differenti-
ation or brain patterning in the early embryo [9,10]. Inter-
estingly, the absence of Nogo-A/RTN4 and the use of
Nogo-blocking antibodies have been shown to increase the
rate of radial migration in hippocampal, cortical and
cerebellar neuronal progenitors [4,5]; to impair synaptic
potentiation in the hippocampus [7]; and to affect the size
of cerebellar postsynaptic densities [8]. This is consistent
with a significant role of mammalian RTN4/Nogo-A as a
negative regulator of cortical plasticity in developmentally
older embryos, in contrast to our observations in fish, in
which defects appeared much earlier in development.
Notably, the authors of a recent report uncovered
distinct neurodevelopmental roles for the mouse Delta
20 and Nogo-66 regions [21]. In that study, proliferation
of neural stem cells in the adult subventricular zone was
found to be modulated by Nogo-66/NgR1 interactions,
whereas the migration of neuroblasts to the olfactory
bulb was controlled by binding of Delta 20 to a receptor
complex distinct from NgR1. Conservation of related
activities in zebrafish rtn4 paralogues may be relevant to
our finding of reduced neural structures in morphant
embryos. Our data further suggest that the function of
Nogo genes evolved independently in fish and mammals,
with an early developmental role becoming more pre-
dominant in the former and a later function in cortical
development and plasticity in the latter. We presently do
not know whether this difference might involve the ac-
tion of the Delta 20-like region of zebrafish rtn4b as an
inhibitor or a repulsive cue during cell–cell interaction
and axon growth. Remarkably, although zebrafish and
mammalian Nogo-66 are almost 70% homologous, the
interaction of zebrafish Nogo-66 (of Rtn4a) and NgR
does not lead to inhibition of neurite growth in fish or
mammalian neurons but to axon growth [15]. Hence, it
remains to be clarified how the inhibitory potential of
Rtn4a and Rtn4b may have evolved differentially in fish
and mammals.
The reduced brain size and aberrant axonal pathways
seen upon rtn4a and rtn4b knockdown could theoreticallyresult from insufficient signaling through NgR (and core-
ceptors), but this phenomenon remains to be analyzed.
Interestingly, although NgR1 is expressed in the embryonic
zebrafish brain [22], its downregulation is known to cause
pathfinding errors only in PNS axons [16]. It is presently
unknown whether CNS fiber tracts are affected by NgR
knockdown or whether the Nogo-66 domain of Rtn4b
binds to NgR. Similarly, whether the Delta 20-like region of
Rtn4b binds to a receptor complex resembling the mam-
malian amino-Nogo-A receptor complex needs to be clari-
fied. Yet, some conservation between the interactions of
Delta 20 and Nogo-A receptor in fish and mammals is
expected, based on their sequence similarity [18] and on
the fact that fish axons recognize mouse Nogo-A Delta
20 [15,23].
Most assumptions about the function of RTN4A/
Nogo-A are based on its cell surface expression. How-
ever, it should be noted that this protein is by far more
abundant in the endoplasmic reticulum (ER), where it
has been proposed to play a role in structuring the
membranous network [24-26]. It has also been reported
to be upregulated in mammalian RGCs after optic nerve
transection, but no concrete function has been asso-
ciated with this phenomenon [27]. The subcellular lo-
calization of the zebrafish Rtn4 homologues has not
been examined in detail, but Nogo-66 has been shown
to reside in and on glial cells in the adult regenerating
optic nerve [19], as was also demonstrated for mamma-
lian Nogo-66 and the Nogo-A-specific region [3].
Conclusions
Both rtn4a and rtn4b functions are required during early
zebrafish development, as their downregulation has
more dramatic effects in brain patterning than rtn4
knockout in mammals. This is somewhat surprising,
given the fact that zebrafish rtn4b and mouse Rtn4 are
expressed in the neural tube and at comparably early
stages of brain development [3]. Duplication of genes is
often accompanied by the acquisition of a new function
of one or both duplicates, as judged by their temporal or
spatial expression patterns [28]. Even though rtn4a and
rtn4b differ partially in their expression domains, in that
rtn4a is, for instance, expressed in somites and rtn4b is
expressed in the spinal cord and notochord, their ex-
pression patterns large overlap. Moreover, their down-
regulation causes similar abnormalities in forebrain and
midbrain morphology as well as in rudimentary and
aberrant retinotectal projections. The most significant
differences between rtn4b and rtn4a morphants was the
immobility and lethality of rtn4b at 5 dpf and the signifi-
cant recovery and nearly normal outer appearance
observed at this time in rtn4a. This difference might be
causally related to an important function of the zebrafish
Rtn4b N terminus, which, like mouse Nogo-A but unlike
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motifs [18]. Nogo-A Delta 20 has been identified as a
CNS myelin-associated inhibitor of axon growth and
regeneration in the adult mammalian CNS and regulator
of plasticity [3]. In this context, it will be interesting to
explore the biological properties of the zebrafish Rtn4b
Delta 20-like domain and its expression in adult fish,
particularly because zebrafish successfully regenerate
RGC axons in the optic nerve and fiber tracts in the
spinal cord [14,29].
Methods
Zebrafish (Danio rerio) were maintained at 28°C under
a 14-hour light, 10-hour dark cycle [30]. Developmental
stages are indicated based on those described by Kimmel
et al. [31] and in hours and days postfertilization (hpf and
dpf, respectively). Some embryos were raised in fish water
containing 0.003% 1-phenyl 2-thiourea to prevent pigmen-
tation [32]. A zebrafish reporter line expressing GFP under
the control of the sonic hedgehog gene promoter tg(shh:gfp)
was obtained from Max-Planck-Institute Developmental
Biology (Tübingen, Germany). tg(hb9:gfp)-transgenic zebra-
fish expressing GFP in motor axons were provided by D
Meyer (University of Innsbruck, Austria). tg(Isl1:gfp) zebra-
fish expressing GFP in cranial motor neurons were pro-
vided by S Higashijima (Okazaki Institute for Integrative
Bioscience, Higashiyama, Japan) and tg(brn3c:mgfp) zebra-
fish expressing membrane-targeted GFP in retinal axons
were provided by H Baier (University of California, San
Francisco, USA).
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed as
described previously [33]. We cloned 1.3 kb of rtn4a-l, 1 kb
of rtn4a-m and 0.9 kb of rtn4a-n (including the full open
reading frames (ORFs) and 393 bp from the 3′UTR and
1.5 kb from the rtn4b N terminus, including the M1 to M4
motifs) in pCRII TOPO (Invitrogen, Carlsbad, CA, USA)
and used them as templates for the synthesis of two inde-
pendent RNA in situ hybridization probes with the DIG
RNA Labeling Kit (Roche Applied Science, Penzberg,
Germany). Transcription patterns were visualized using an
Axioplan 2 compound microscope (Carl Zeiss Microscopy,
Oberkochen, Germany) using Nomarski (differential
interference contrast) optics, photographed with a Zeiss
Color Axiocam and further processed using Adobe
Photoshop 12.0 software (Adobe Systems, San Jose, CA,
USA).
Cloning full-length rtn4a and rtn4b cDNAs
The rtn4a full coding sequence was amplified by RT-PCR
from 1-dpf zebrafish embryo total RNA with the following
primers: forward rtn4a-fw 5′-atgcagccgcaggagtacat-3′ and
reverse rtn4a-rv 5′-ggctgccgggtcacgact-3′. The rtn4bcDNA was amplified with forward primer rtn4b-fw
5′-gtcctgagctgcgctatttc-3′ and reverse primer rtn4b-rv
5′-gttatttagtaggcagcggtgtg-3′ by RT-PCR from total RNA
extracted from adult zebrafish optic nerve. First-strand
cDNA was synthesized under standard conditions with
the SuperScript First-Strand Synthesis System (Invitrogen)
using an oligo(dT) primer. All of the above-mentioned
PCR experiments were done with Phusion High-Fidelity
DNA Polymerase (Finnzymes/Thermo Fisher Scientific,
Espoo, Finland). Full-length cDNAs were cloned into a
PCR2.1 TOPO vector (Invitrogen) and sequenced.Morpholino knockdowns and mRNA rescue
The following MOs were purchased from Gene Tools
(Philomath, OR, USA) and designed to target independ-
ent sequences at the 5′ UTRs and the start codon of the
zebrafish rtn4a and rtn4b, including known splice vari-
ants based on the following sequence data obtained from
the GenBank database (see Additional file 2):
rtn4a-l, 5′-taaagtaacttcaagatgcgccgga-3′ (position on
mRNA −55/−30) and 5′-tcgtggagcttatttgatcatccat-3′ (pos-
ition on mRNA 1/25) [GenBank:AY555039.1]; rtn4a-m, 5′-
cgtgcatcggtcatatatccagtca-3′ (position on mRNA −18/+7)
and 5′-ttatctgaattggcgtgcatcggtc-3′ (position on mRNA −
5/+20) [GenBank:AY555042.1]; rtn4a-n, 5′-ctcgctcattctgc
gatcagacagcc-3′ (position on mRNA −25/0) and 5′-gctccac
cacttgtttggaatccat-3′ (position on mRNA 1/25) [GenBank:
AY555043.1]; rtn4b, 5′-ccactgcgggagaactcagaacagc-3′ (pos-
ition on mRNA −81/−57, for better distinction, rtn4b-
MO-1) and 5′-gctcgttctgtgtcctccatcggga-3′ (position on
mRNA −5/+20, rtn4b-MO-2) [RefSeq:NM_001040335.1];
control, 5′-aacgaacgaacgaacgaacgaacgc-3′.
In addition to ATG-targeting MOs, as described by
Brösamle and Halpern [16], we used MOs directed
against 5′UTR sequences of the rtn4a splice variants.
All microinjections were performed at early cleavage
stages (one- to four-cell stage) using a manual micromanip-
ulator (Narishige, Tokyo, Japan) coupled to a Transjector
5246 (Eppendorf, Hamburg, Germany) under a Stemi 2000
stereomicroscope (Carl Zeiss Microscopy). After running
specificity and dose-dependency controls, MOs were
injected at a concentration of 0.5 or 1.0 ng/nl in 13 Danieau
buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4,
0.6 mM Ca(NO3)2, 5.0 mM 2-[4-(2-hydroxyethyl)piperazin-
1-yl]ethanesulfonic acid [pH 7.6]) and 0.125% Phenol Red
(Sigma-Aldrich, St Louis, MO, USA).
For MO rescue experiments, rtn4a-l was cloned in
frame with GFP into the EcoRI/ApaI restriction sites of
pGFP-N1. RTNa-l-gfp, rtn4a-l and rtn4b ORF cDNAs
were subcloned into the EcoRI/XbaI (rtn4al-gfp), EcoRI/
XbaI (rtn4a-l) or EcoRI/StuI (rtn4b) restriction sites of
pCS2+ (provided by Z Varga, University of Oregon,
Eugene, OR, USA) and transcribed in vitro using the
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For mRNA synthesis, DNA templates were linearized
with BssHII. After synthesis, template DNA was re-
moved by DNaseI digestion of the rtn4a-l and rtn4b
mRNAs. rtn4a-l or rtn4b MO at 1.0 ng/nl in 13 Danieau
buffer were coinjected with capped mRNAs at 20 or
100 pg/nl at a 1:1 ratio in 0.05 M KCl and 0.125% Phe-
nol Red. For overexpression experiments, mRNAs were
microinjected at 100 pg/nl. At least 200 embryos per
experiment were microinjected (5-nl injection volume)
and kept in E3 medium (5 mM NaCl, 0.17 mM KCl,
0.33 mM CaCl2 and 0.33 mM MgSO4) at 28°C. Quantifi-
cation of phenotypes was carried out on 200 embryos
per experiment, from among which a smaller number
were selected for detailed analysis. Images were acquired
using a SteREO Lumar.V12, Axioplan 2 or confocal laser
scanning microscope LSM 710 (Carl Zeiss Microscopy).
Images were further processed using Adobe Photoshop
12.0 software.
Immunohistochemistry
Anesthetized embryos (6 to 24 hpf) were fixed in 4% para-
formaldehyde (PFA) in phosphate-buffered saline (PBS) for
2 hours at room temperature (RT) or overnight at 4°C.
Embryos/larvae older than 48 hpf were fixed in PFA for 30
minutes at RT, washed in PBS-Tween 20 (PBST) and
permeabilized in acetone for 7 minutes at −20°C. The fol-
lowing antibodies and concentrations were used for whole-
mount immunohistochemistry: polyclonal anti-neurolin,
1:500 [34]; monoclonal antiacetylated tubulin, 1:1,000
(Sigma-Aldrich) and the monoclonal anti-HuC/HuD neur-
onal protein (16A11) 1:1,000 (Molecular Probes, Sunnyvale,
CA, USA). For staining with the polyclonal Rtn4a antibody
(IK964, which was generated in our laboratory) diluted
1:250 [15], PFA fixation was not used. Instead, embryos
were incubated on ice in 50% methanol in PBS, pH 7.4
(2 minutes), 100% MeOH (5 minutes) and 50% MeOH in
PBS (2 minutes). To generate a polyclonal antibody against
zebrafish Rtn4b, the rtn4b-M1-M4 region [18] was ampli-
fied by PCR from a pCR2.1 TOPO vector containing the
rtn4b ORF. Forward rtn4b-M1-fw 5′-GGGAATTC
TAGCCCGTCTCCAGACCTGCTCCAGGA-3′ and re-
verse rtn4b-M4-rv 5′-GGGTCGACCTA-CTGCAGACC
CTGGAGCAGCTCTGCC-3′ primers containing EcoRI
and SalI restriction enzyme sites were designed to amplify
490 bp, including the M1 to M4 motifs. The PCR product
was digested with EcoRI and SalI and cloned in frame into
the pGEX-4 T-3 glutathione S-transferase expression vector
(GE Healthcare Life Sciences, Freiburg, Germany) after the
thrombin cleavage site. The recombinant protein was used
to immunize a rabbit to produce the polyclonal antibody
K1121. The immunopurified Rtn4b antibody was used at a
dilution of 1:500.Nuclei were counterstained with 100 ng/ml DAPI,
together with the secondary antibody, for 30 minutes at
RT. The secondary antibodies were cross-purified with
fluorophore-conjugated goat anti-rabbit and cyanine 3 or
Alexa Fluor 488–coupled anti-mouse antibodies in which
specimens were incubated overnight at 4°C. For analysis
of Rtn4 expression levels, embryos were dechorionated,
deyolked, lysed and analyzed by Western blotting. Blots
were exposed to polyclonal Rtn4a antibody (IK964; di-
luted 1:10,000) and polyclonal Rtn4b antibody (K1121;
diluted 1:1,000) and to a monoclonal antibody against
GFP (diluted 1:2,000 to detect Rtn4al-GFP; Roche
Applied Science).
Bromodeoxyuridine labeling
To label cells in the S-phase, embryos were immersed in
10 mM BrdU (Sigma-Aldrich) in 1% dimethyl sulfoxide
in E3 medium. Embryos were incubated for 1 hour at
28°C and washed in E3 medium (three timer for 5 mi-
nutes), fixed in 4% PFA overnight at 4°C and dehydrated
in methanol at −20°C. After gradual rehydration, embryos
were permeabilized with proteinase K (10 μg/ml) followed
by postfixation with 4% PFA, washed with PBST, blocked
with 10% normal goat serum in PBST for at least 2 hours
at room temperature and incubated with mouse anti-
BrdU-fluorescein isothiocyanate antibody (1:200; Sigma-
Aldrich) in 4% blocking solution overnight at 4°C.
Acridine orange staining
To get an impression of the extent of apoptosis, 1-dpf
live embryos were incubated in 2 μg/ml acridine orange
(Sigma-Aldrich) for 30 minutes, followed by three rinses
in E3 medium. Embryos were anesthetized in 0.016%
Tricaine methanesulfonate (MS-222; Sigma-Aldrich) and
photographed (Zeiss Lumar.V12 stereomicroscope).
Motility tests
To evaluate the escape response, 3-dpf embryos were
touched with the tip of a fine needle twice at the dorsal
tip of the tail. Embryos that did not react were classified
as nonmotile. Three groups of at least 50 embryos were
tested in each experiment.
Quantifications
To quantify total cell numbers and axon branching of
motor neurons in tg(hb9:gfp), control and rtn4b-MO1-
injected embryos, six representative specimens from
each group were fixed at 1 and 2 dpf, respectively, and
their trunk regions were scanned by confocal microcopy.
All fluorescent cells (trunk segments 15 to 18) and
axonal projections (trunk segments 5 to 8 and 15 to 18)
were counted in z-stack confocal reconstructions. Em-
bryos exhibiting aberrant branching and mistakes in
pathfinding of their motor axons were classified as mild,
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categorized as strong. The size of the eye and the area
covered by RGCs, as well as the areas of the optic
tectum, forebrain and neuropil, were determined in tg
(Brn3c:mgfp) control, rtn4a-l and rtn4b MO1-injected
embryos, with 10 representative specimens at 3 and 5
dpf. Areas were measured in ImageJ software (National
Institutes of Health, Bethesda, MD, USA) by using ven-
tral and dorsal z-plane projections of the head. Data are
represented as mean values, and error bars indicate the
standard error of the mean. Data were analyzed using
analysis of variance (ANOVA) and paired t-test were
used after determining whether the sample datasets
conform to a normal distribution. P-values are indicated
as follows: *P ≤ 0.05. **P ≤ 0.01.
Additional files
Additional file 1: Toxicity of rtn4a morpholino-mediated knockdown.
(A) Impaired development and viability after injection of rtn4-morpholino
(MO). Embryos were microinjected at cell stages 1 to 4 and analyzed at 6 hpf
and 15 hpf. Higher doses of rtn4a-MO resulted in delayed gastrulation at 6 hpf
and reduced viability at 15 hpf compared to control embryos (arrowhead).
(B) rtn4a and rtn4b MOs were microinjected at 2.5 or 5.0 ng. Mortality,
development and viability were evaluated for all experimental groups in at
least three experiments. Embryos showing a curly tail phenotype upon Rtn4a
knockdown were excluded from the experimental group. (C) Quantification of
embryos with reduced anterior brain structures was carried out after
knockdown of each Rtn4a isoform. Control (n = 95), rtn4a-l MO1 (n= 78),
rtn4a-m MO1 (n= 23), rtn4a-n MO1 (n= 33) and rtn4a (l, m and n) MO1
(n= 78). (D) A second rtn4b-MO sequence (rtn4b-MO2) elicited the same
phenotype as the rtn4b-MO1 sequence. At 15 hpf, the forebrain was flattened
and the sizes of the head and eye anlage were reduced. At 1 dpf, rtn4b-MO2-
injected embryos were smaller than control embryos, with reduced heads and
eyes. Embryos also had an abnormally curved notochord. At 2 dpf, rtn4b
morphants had shortened fore- and midbrain regions. At 3 dpf, rtn4b
morphants developed a thinner tail, which curved ventrally, lacked lower jaws
and had an inflated heart cavity. At 5 dpf, they did not recover any of the
abnormalities seen at 3 dpf. (E) Acetylated tubulin staining of 2-dpf embryos
injected with 5 ng of rtn4a MO revealed pathfinding mistakes of the lateral
line. (F) Proportion of embryos with aberrant pathfinding of the lateral line at
2 dpf after injection of a mixture of 2 ng (n= 45) or 5 ng (n= 75) of each
isoform of rtn4a-MO (arrow).
Additional file 2: Table S1. Morpholino effect in retinal ganglion cells
under different rtn4 MO concentrations.
Additional file 3: Immunostaining of morphant embryos confirms
the specificity of Rtn4a and Rtn4b antibodies. (A) In 1 dpf control
morpholino-injected embryos, the Rtn4a antibody labeled neural
structures such as the neural tube. Upon morpholino knockdown of all
rtn4a isoforms (C) or the rtn4a-l isoform only (E), the signal appeared
clearly reduced. Similarly, at 2 dpf, labeling of retinal ganglion cells (RGCs)
and optic nerves (arrow) in control embryos (B) was reduced after
knockdown of all or only the rtn4a-l isoforms (D) and (F). (G) and (H) In
control embryos, antibodies against Rtn4b labeled RGCs (arrow) (G),
spinal cord (arrow) and motor neurons (arrowheads) (H). The signal in
these structures was drastically reduced after Rtn4b downregulation (I)
and (J). (A), (C) and (F) show dorsal views (rostral to the left). (B), (D), (F),
(G) and (I) show ventral views (rostral at the top). (H) and (J) show lateral
views (rostral to the left).
Additional file 4: Rtn4b morphants in brn3c:mGFP transgenic
embryos. (A) Branching of motor neurons in rtn4b morphants. Axonal
projections (trunk segments 5 to 8 and 15 to 18) were analyzed. In mild
phenotypes, motor axons showed misbranching and pathfinding
mistakes, whereas in strong phenotypes defasciculation was alsoobserved. (B) Proportion of abnormal motor axons in anterior and
posterior segments in rtn4b morphants and in the rescue group at 2 dpf.
rtn4b MO1 (n = 19), rtn4b-MO1 and rtn4b-mRNA (n = 25) and rtn4b-mRNA
(n = 20). (C) Proportion of nonmotile embryos at 3 dpf in rtn4b
morphants, rescued and rtn4b-mRNA-injected groups.
Additional file 5: Apoptosis in rtn4 morphant embryos. Comparison
of apoptosis in control (A), rtn4a morphant (B) and rtn4b morphant (C).
Cell death was visualized at 1 dpf by acridine orange staining. (D) and (E)
Quantification of acridine orange intensity in selected areas of the
midbrain (square) and hindbrain (rectangle) showing increased staining
(arrow) in both morphants. Control MO (5.0 ng) (n = 30), rtn4a-l-MO1
(5.0 ng) (n = 25) and rtn4b-MO1 (5.0 ng) (n = 24).
Additional file 6: In vivo bromodeoxyuridine labeling of 1- and
3-day postfertilization rtn4 morphant embryos. (A) Overview of the
bromodeoxyuridine (BrdU) pulse chase experiment. To maximize the
labeling of cells entering the S-phase, a 1-hour BrdU pulse was applied at
1 dpf. Half of the embryos were fixed immediately after the pulse (B),
(D), (F), (J), (K) and (L), and the other half were fixed 2 days later (C), (E),
(G), (M), (N) and (O). Confocal maximum projections of midbrain and
hindbrain sections showed a considerable amount of BrdU-labeled cells
at 1 dpf (green) (B), (D), (F), (J), (K) and (L). Nuclei were counterstained
with 4′,6-diamidino-2-phenylindole (DAPI) (red). At 1 dpf, the presumptive
tectum of rtn4a morphants (D), especially rtn4b morphants (F), is reduced
in size relative to control embryos (B). (C), (E), (G), (M), (N) and (O) BrdU
retention in the tectum and hindbrain at 3 dpf. In addition to the
reduced tectum in 1-dpf rtn4a and rtn4b morphants, cells in the 3-dpf
rtn4b morphants show strong BrdU signaling 2 days after the BrdU chase
(G) and (O). Only weak and diffused BrdU signaling was detected in rtn4a
(E) and (N) and control (C) and (M) groups. (H) and (P) Quantification of
total cells (red) and proliferating cells (green) in the tectum and hindbrain
at 1 dpf in rtn4a and rtn4b morphants and the control group. (I)
Quantification of total cells in the tectum at 3 dpf (red). (Q) Quantification
of total (red) vs. BrdU-positive cells (yellow) in analyzed areas of the
hindbrain at 3 dpf in rtn4a and rtn4b morphants and the control group.
*Melanocytes. Control (1 dpf; n = 8), rtn4a (n = 11), rtn4b (n = 12), control
2 dpf (n = 6), rtn4a (n = 6) and rtn4b (n = 14). Scale bar = 50 μm.
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